Magnetar Financial LLC Invests $390,000 in Maximus, Inc. $MMS

Key Points

• Magnetar Financial LLC has taken a new position in Maximus, Inc. by purchasing 5,715 shares worth approximately $390,000 during the first quarter, as reported in their recent SEC filing.
• In recent earnings results, Maximus reported $2.16 earnings per share, exceeding analysts' expectations of $1.39, and indicated a revenue of $1.35 billion for the quarter.
• Maximus announced a quarterly dividend of $0.30 per share, representing an annualized yield of 1.4% and a dividend payout ratio of 22.10%.

Magnetar Financial LLC purchased a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 5,715 shares of the health services provider's stock, valued at approximately $390,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Caitong International Asset Management Co. Ltd grew its holdings in shares of Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after acquiring an additional 526 shares during the period. UMB Bank n.a. boosted its holdings in shares of Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. boosted its holdings in shares of Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. boosted its holdings in shares of Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Trading Down 0.3%

Shares of MMS traded down $0.29 during trading hours on Friday, hitting $88.23. The stock had a trading volume of 493,501 shares, compared to its average volume of 603,023. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The firm has a market cap of $4.97 billion, a P/E ratio of 16.25 and a beta of 0.61. The company's fifty day simple moving average is $78.21 and its 200 day simple moving average is $72.36. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business's quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the company posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is 22.10%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company's stock. According to MarketBeat, Maximus currently has a consensus rating of "Strong Buy" and a consensus target price of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.